Author

E. Mevel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A.-G. Marcelin· 2 shared B. Vanhove· 2 shared C. Ciron· 2 shared E. Lheriteau· 2 shared F. Raffi· 2 shared G. Evanno· 2 shared O. Duvaux· 2 shared P.-J. Royer· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A.-G. Marcelin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)

B. Vanhove, S. S. Marot, G. Evanno, I. Mallet, G. Rouvray, F. Shneiker, E. Mevel, C. Ciron, J. Rousse, P.-J. Royer, E. Lheriteau, F. Raffi, O. Duvaux, A.-G. Marcelin, V. Calvez

bioRxiv · Jan 26, 2022 · PreprintImmunology

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.

B. Vanhove, S. S. Marot, R. So, B. Gaborit, G. Evanno, I. Malet, G. Lafrogne, E. Mevel, C. Ciron, P.-J. Royer, E. Lheriteau, F. Raffi, R. Bruzzone, C. K. P. Mok, O. Duvaux, , V. Calvez

XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 Spike RBD, neutralizes multiple variants by targeting multiple epitopes and shows potential in clinical trials.

bioRxiv · Apr 2, 2021Immunology

Generation of two Multipotent Mesenchymal Progenitor Cell Lines Capable of Osteogenic, Mature Osteocyte, Adipogenic, and Chondrogenic Differentiation

M. Prideaux, C. S. Wright, M. L. Noonan, X. Yi, E. L. Clinkenbeard, E. Mevel, J. A. Wheeler, S. Byers, U. Sankar, K. E. White, G. J. Atkins, W. R. Thompson

The paper develops two mesenchymal progenitor cell lines that can differentiate into osteogenic, adipogenic, and chondrogenic lineages and mimic in vivo responses of key regulatory genes.

bioRxiv · Nov 19, 2020 · PreprintCell Biology